BioSove is a research institute focused on a single question:
Why do breakthrough biological treatments remain inaccessible to most patients who need them?
We don't work in laboratories. We work in the space between the laboratory and the patient — studying the regulatory, economic, logistical, and social barriers that determine whether a scientific breakthrough becomes an available treatment or stays locked in a journal.
Our Belief
The next great leap in medicine won't come from discovering new cures. It will come from delivering the cures we already have.
Methodology
We combine health economics research, regulatory analysis, and systems thinking to map the barriers between breakthrough and patient. Our work is grounded in data, anchored to specific costs and timelines, and written for both experts and the informed public.
Reach Out
BioSove is in its early research stage. We are building a foundation of analysis before seeking formal partnerships — but we want to hear from you.
For Researchers If you work on health economics, regulatory science, or treatment accessibility, we're particularly interested in:
- Cost structure data for biological treatments
- Comparative regulatory analysis across jurisdictions
- Alternative economic models for rare disease treatment
For Policymakers Our research is designed to be actionable. If you work in healthcare policy or drug pricing regulation, our upcoming reports may be relevant to your work.
For Patients and Advocates We write for you. If you have a story about treatment access barriers, it matters to our research.
Use the contact form below. We read every message.